Hemu Bio

Hemu Bio

荷牧生物

Hemu Bio

Other

Hemu Biotechnology was jointly established by an advanced domestic technology development team and a strong management team. It is China's first innovative R&D company focused on next-generation mRNA vaccines for animals.

Latest round: Series A Extension (2026)

Source: ChinaBulls — chinabulls.com

Last updated 2026-01-01

Funding history

Request access to view this section.

Investors

Request access to view this section.

HQ & website

Request access to view this section.

Tags

Request access to view this section.